“OncoDynamiX” is a novel mechanism based platform developed by TheraIndx for oncology drug discovery and development.

OncoDynamiX reduces lead time with significant cost saving at the discovery stage by selection of appropriate cell lines based on signalling pathways associated with the drug target for LI-LO programs, and also identifies appropriate biomarkers for PK/PD and enables identification of patients for clinical trials to optimise drug response.

OncoDynamix Predicts Effect of Drug in Cell and Patient Populations Based on Pathway Mechanisms

OncoDynamiX : In what Cell, Tumor and Patient Populations will an Anti-Cancer Agent (s) Most Likely to Work?